NCT02355158View on ClinicalTrials.gov

A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Painful Diabetic NeuropathyDiabetes
Interventions
DRUG

clonidine hydrochloride topical gel, 0.1%

Trial Locations (20)

27103

Winston-Salem

31904

Columbus

33143

Miami

33401

West Palm Beach

33458

Jupiter

33511

Brandon

33606

Tampa

34205

Bradenton

63042

Hazelwood

66160

Kansas City

75230

Dallas

77030

Houston

77074

Houston

78229

San Antonio

85023

Phoenix

90404

Santa Monica

94598

Walnut Creek

98507

Renton

06708

Waterbury

02886

Warwick

Sponsors
All Listed Sponsors
lead

BioDelivery Sciences International

INDUSTRY

NCT02355158 - A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic Neuropathy | Biotech Hunter | Biotech Hunter